IRLAB Therapeutics AB 2022 Annual Report
Company: IRLAB Therapeutics AB
Sector: Manufacturing
Country: Sweden
Year: 2022
Type: Annual Report
Pages: 68
The report highlights IRLAB's expanded portfolio, including the nomination of IRL757 in 2022. Its sustainability section focuses on employees, responsible dealings and community involvement. Consolidated group net revenue was 61,136 TSEK in 2022, from licensing and service activity.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.